AlphaGrep UK’s Kadant KAI Stock Holding History

AlphaGrep UK’s Portfolio KAI Stock Details KAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-821	Closed	-$240K	–	843
2026 Q1	$240K	Buy	+821	New	+$264K	0.07%	617

Other funds holding KAI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AlphaGrep UK's KAI Position: Q2 2026 in Review

AlphaGrep UK sold out of Kadant (KAI) in Q2 2026, closing a stake of 821 shares — an estimated $240K sold.

AlphaGrep UK first reported a position in KAI in Q1 2026 and held it in 1 quarter. The position peaked at $240K in Q1 2026. 304 funds tracked by Wall St. Rank hold KAI as of Q2 2026.

AlphaGrep UK reported no remaining Kadant position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 821 Kadant shares in Q2 2026, an estimated $240K.
AlphaGrep UK first reported a position in Kadant in Q1 2026 and held it in 1 quarter.
AlphaGrep UK's Kadant position peaked at $240K in Q1 2026.
304 funds tracked by Wall St. Rank held Kadant as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.